Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Ethan Allen CEO Farooq Kathwari Talks Tariffs, Cautious Consumers
06:32

Yale Budget Lab Executive Director Martha Gimbel Talks Tariffs
05:24

Apollo's Jim Zelter Talks Iran War, Private Credit Concerns
10:35